Abstract
Background Limited data are available on sex differences in the time to treatment of cardiogenic shock (CS) with and without acute myocardial infarction (AMI).
Methods For this retrospective cohort study, we used nationally representative hospital survey data from the National Inpatient Sample (years 2016-2021) to assess sex differences in interventions, time to treatment (within versus after 24 hours of admission), and in-hospital mortality for AMI-CS and non-AMI-CS, adjusting for age, race, income, insurance, comorbidities, and prior cardiac interventions.
Results We identified 1,052,360 weighted CS hospitalizations (60% non-AMI-CS; 40% AMI-CS). Women with CS had significantly lower rates of all interventions. For AMI-CS, women had a higher likelihood of in-hospital mortality after: revascularization (adjusted odds ratio (aOR) 1.15 [95% CI 1.09-1.22]), mechanical circulatory support (MCS) (1.15 [1.08-1.22]), right heart catheterization (RHC) (1.10 [1.02-1.19]) (all p<0.001). Similar trends were found for the non-AMI-CS group. Women with AMI-CS were less likely to receive early (within 24 hours of admission) revascularization (0.93 [0.89-0.96]), MCS (0.76 [0.73-0.80]), or RHC (0.89 [0.84-0.95]) than men; women with non-AMI-CS were less likely to receive early revascularization (0.78 [0.73-0.84]), IABP (0.85 [0.78-0.94]), pLVAD (0.88 [0.77-0.99]) or RHC (0.83 [0.79-0.88]) than men (all p<0.001). For both types of CS, in-hospital mortality was not significantly different between men and women receiving early ECMO, pLVAD, or PCI.
Conclusions Sex disparities in the frequency of treatment of CS persist on a national scale, with women being more likely to die following treatment and less likely to receive early treatment. However, when comparing patients who received early treatment, in-hospital mortality does not differ significantly when men and women are treated equally within 24 hours of admission. Early intervention if clinically indicated could mitigate sex-based differences in CS outcomes and should be made a priority in the management of CS.
Clinical Perspective What is new?
Women have increased in-hospital mortality with cardiogenic shock and have lower odds of early intervention (within 24 hours of admission) compared to men.
When men and women with cardiogenic shock are treated equally in terms of early intervention within 24 hours of admission, sex differences in in-hospital mortality disappear.
What are the clinical implications?
Sex-based disparities are present in the utilization of treatment and time to intervention for patients with cardiogenic shock.
Early recognition and intervention for cardiogenic shock among women should be considered to improve clinical outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Dr. Minhas is supported by NIH/NHLBI K23HL171886.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB was used, given that this project utilized de-identified national hospitalization data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Sources of Funding Dr. Minhas is supported by NIH/NHLBI K23HL171886.
Disclosures None
Data Availability
The data used in this study was adapted from the National Inpatient Sample database and is, therefore, unavailable for public posting. The data is available for purchase on the Agency for Healthcare Research and Quality website.
https://hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp
Abbreviations
- CS
- Cardiogenic Shock
- AKI
- Acute Kidney Injury
- AMI
- Acute Myocardial Infarction
- MCS
- Mechanical Circulatory Support
- RHC
- Right Heart Catheterization
- HCUP
- Healthcare Cost and Utilization Project
- NIS
- National Inpatient Sample
- PCI
- Percutaneous Intervention
- CABG
- Coronary Artery Bypass Graft
- IABP
- Intra-Aortic Balloon Pump
- pLVAD
- Percutaneous Left Ventricular Assist Device
- LVAD
- Left Ventricular Assist Device
- ECMO
- Extracorporeal Membrane Oxygenation
- aOR
- Adjusted Odds Ratio
